These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 30261564

  • 1. Ipilimumab-associated halo-like inflammatory reactions around nevi during therapy for metastatic melanoma.
    Alniemi DT, Fischer A, Greene LA, Pierson JC.
    Dermatol Online J; 2018 Jul 15; 24(7):. PubMed ID: 30261564
    [Abstract] [Full Text] [Related]

  • 2. Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab).
    Hwang SJE, Fernández-Peñas P.
    Curr Probl Dermatol; 2018 Jul 15; 53():82-92. PubMed ID: 29131040
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.
    Hwang SJ, Carlos G, Wakade D, Byth K, Kong BY, Chou S, Carlino MS, Kefford R, Fernandez-Penas P.
    J Am Acad Dermatol; 2016 Mar 15; 74(3):455-61.e1. PubMed ID: 26793994
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous Eruption Secondary to Immunotherapy for Metastatic Melanoma Limited to Sites of Locoregional Melanoma Metastases: A Possible Variant of Locus Minoris Resistentiae.
    Donaldson M, Owen JL, Choi JN.
    JAMA Dermatol; 2018 Jul 01; 154(7):846-847. PubMed ID: 29800007
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.
    Coleman E, Ko C, Dai F, Tomayko MM, Kluger H, Leventhal JS.
    J Am Acad Dermatol; 2019 Apr 01; 80(4):990-997. PubMed ID: 30399387
    [Abstract] [Full Text] [Related]

  • 9. Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma.
    Adler NR, Murray WK, Brady B, McCormack C, Pan Y.
    Clin Exp Dermatol; 2018 Jun 01; 43(4):497-499. PubMed ID: 29396853
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma.
    Perret RE, Josselin N, Knol AC, Khammari A, Cassecuel J, Peuvrel L, Dreno B, Supported by GESTIM Nantes group of cutaneous adverse events induced by anticancer drugs.
    Int J Dermatol; 2017 May 01; 56(5):527-533. PubMed ID: 28188628
    [Abstract] [Full Text] [Related]

  • 12. Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma.
    Alnabulsi R, Hussain A, DeAngelis D.
    Orbit; 2018 Oct 01; 37(5):381-384. PubMed ID: 29381409
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.
    Chen WS, Tetzlaff MT, Diwan H, Jahan-Tigh R, Diab A, Nelson K, Glitza IC, Kaunitz GJ, Johnson D, Torres-Cabala C, Pacha O, Taube JM, Maloney K, Prieto VG, Curry JL.
    J Cutan Pathol; 2018 Oct 01; 45(10):764-773. PubMed ID: 29943453
    [Abstract] [Full Text] [Related]

  • 15. Diet-dependent toxicity of ipilimumab in metastatic melanoma.
    Majenka P, Hoffmann M, Rötzer I, Dimitrakopoulou-Strauss A, Koschny R, Longerich T, Enk A, Hassel JC.
    Eur J Cancer; 2019 Jan 01; 106():220-224. PubMed ID: 30528806
    [No Abstract] [Full Text] [Related]

  • 16. Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma.
    Hwang SJ, Carlos G, Wakade D, Sharma R, Fernandez-Penas P.
    Melanoma Res; 2016 Aug 01; 26(4):417-20. PubMed ID: 27031538
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.
    Page B, Borradori L, Beltraminelli H, Yawalkar N, Hunger RE.
    J Eur Acad Dermatol Venereol; 2018 Jul 01; 32(7):e256-e257. PubMed ID: 28430376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.